Microbe-Dependent Exacerbated Alveolar Bone Destruction in Heterozygous Cherubism Mice
Mizuho Kittaka, Tetsuya Yoshimoto, Collin Schlosser, Mikihito Kajiya, Hidemi Kurihara, Ernst J Reichenberger, Yasuyoshi Ueki, Mizuho Kittaka, Tetsuya Yoshimoto, Collin Schlosser, Mikihito Kajiya, Hidemi Kurihara, Ernst J Reichenberger, Yasuyoshi Ueki
Abstract
Cherubism (OMIM#118400) is a craniofacial disorder characterized by destructive jaw expansion. Gain-of-function mutations in SH3-domain binding protein 2 (SH3BP2) are responsible for this rare disorder. We have previously shown that homozygous knock-in (KI) mice (Sh3bp2 KI/KI ) recapitulate human cherubism by developing inflammatory lesions in the jaw. However, it remains unknown why heterozygous KI mice (Sh3bp2 KI/+ ) do not recapitulate the excessive jawbone destruction in human cherubism, even though all mutations are heterozygous in humans. We hypothesized that Sh3bp2 KI/+ mice need to be challenged for developing exacerbated jawbone destruction and that bacterial stimulation in the oral cavity may be involved in the mechanism. In this study, we applied a ligature-induced periodontitis model to Sh3bp2 KI/+ mice to induce inflammatory alveolar bone destruction. Ligature placement induced alveolar bone resorption with gingival inflammation. Quantification of alveolar bone volume revealed that Sh3bp2 KI/+ mice developed more severe bone loss (male: 43.0% ± 10.6%, female: 42.6% ± 10.4%) compared with Sh3bp2 +/+ mice (male: 25.8% ± 4.0%, female: 30.9% ± 6.5%). Measurement of bone loss by the cement-enamel junction-alveolar bone crest distance showed no difference between Sh3bp2 KI/+ and Sh3bp2 +/+ mice. The number of osteoclasts on the alveolar bone surface was higher in male Sh3bp2 KI/+ mice, but not in females, compared with Sh3bp2 +/+ mice. In contrast, inflammatory cytokine levels in gingiva were comparable between Sh3bp2 KI/+ and Sh3bp2 +/+ mice with ligatures. Genetic deletion of the spleen tyrosine kinase in myeloid cells and antibiotic treatment suppressed alveolar bone loss in Sh3bp2 KI/+ mice, suggesting that increased osteoclast differentiation and function mediated by SYK and accumulation of oral bacteria are responsible for the increased alveolar bone loss in Sh3bp2 KI/+ mice with ligature-induced periodontitis. High amounts of oral bacterial load caused by insufficient oral hygiene could be a trigger for the initiation of jawbone destruction in human cherubism. © 2020 The Authors. JBMR Plus published by Wiley Periodicals, Inc. on behalf of American Society for Bone and Mineral Research.
Keywords: CHERUBISM; ORAL MICROBES; OSTEOCLASTS; PERIODONTITIS; SH3BP2.
© 2020 The Authors. JBMR Plus published by Wiley Periodicals, Inc. on behalf of American Society for Bone and Mineral Research.
Figures
References
- Ueki Y, Tiziani V, Santanna C, et al. Mutations in the gene encoding c‐Abl‐binding protein SH3BP2 cause cherubism. Nat Genet. 2001;28(2):125–6.
- Ueki Y, Lin CY, Senoo M, et al. Increased myeloid cell responses to M‐CSF and RANKL cause bone loss and inflammation in SH3BP2 “cherubism” mice. Cell. 2007;128(1):71–83.
- Yoshitaka T, Mukai T, Kittaka M, et al. Enhanced TLR‐MYD88 signaling stimulates autoinflammation in SH3BP2 cherubism mice and defines the etiology of cherubism. Cell Rep. 2014;8(6):1752–66.
- Mukai T, Ishida S, Ishikawa R, et al. SH3BP2 cherubism mutation potentiates TNF‐alpha‐induced osteoclastogenesis via NFATc1 and TNF‐alpha‐mediated inflammatory bone loss. J Bone Miner Res. 2014;29(12):2618–35.
- Kittaka M, Yoshimoto T, Schlosser C, et al. Alveolar bone protection by targeting the SH3BP2‐SYK axis in osteoclasts. J Bone Miner Res. 2020;35(2):382–95.
- Wang Q, Garrity GM, Tiedje JM, Cole JR. Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl Environ Microbiol. 2007;73(16):5261–7.
- Prod'Homme V, Boyer L, Dubois N, et al. Cherubism allele heterozygosity amplifies microbe‐induced inflammatory responses in murine macrophages. J Clin Invest. 2015;125(4):1396–400.
- Currie KS, Kropf JE, Lee T, et al. Discovery of GS‐9973, a selective and orally efficacious inhibitor of spleen tyrosine kinase. J Med Chem. 2014;57(9):3856–73.
- Bosshardt DD, Lang NP. The junctional epithelium: from health to disease. J Dent Res. 2005;84(1):9–20.
- Bernimoulin JP. Recent concepts in plaque formation. J Clin Periodontol. 2003;30(Suppl 5):7–9.
Source: PubMed